Article
Clinical mechanism of ribavirin action in Hepatitis C treatment: insights from the STOPHCV-1 randomised trial
2026-04-15
Abstract excerpt
<h4>Background</h4> Ribavirin is a guanosine analogue with clinical antiviral activity against a range of RNA viruses including hepatitis C virus (HCV), respiratory syncytial virus and Lassa virus. Several potential mechanisms of action have been proposed, but there is limited data supporting them clinically. <h4>Methods</h4> We studied 196 HCV-infected participants from a trial of short-course directly antivira...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a0d8cee5-2f41-561f-87b8-40c175749fae
- DOI
- 10.64898/2026.04.14.26350846
